Iron Triangle Partners LP - Q2 2020 holdings

$397 Million is the total value of Iron Triangle Partners LP's 24 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 61.5% .

 Value Shares↓ Weighting
EHC BuyENCOMPASS HEALTH CORP$34,062,000
+33.0%
550,000
+37.5%
8.58%
-13.4%
HOLX NewHOLOGIC INC$28,500,000500,000
+100.0%
7.18%
BAX BuyBAXTER INTL INC$28,413,000
+250.0%
330,000
+230.0%
7.16%
+127.8%
HZNP SellHORIZON THERAPEUTICS PUB LTD$24,240,000
+63.7%
436,127
-12.8%
6.10%
+6.6%
CRL BuyCHARLES RIV LABS INTL INC$22,666,000
+79.6%
130,000
+30.0%
5.71%
+16.9%
BSX  BOSTON SCIENTIFIC CORP$21,066,000
+7.6%
600,0000.0%5.30%
-29.9%
CTLT BuyCATALENT INC$20,524,000
+97.5%
280,000
+40.0%
5.17%
+28.6%
IQV NewIQVIA HLDGS INC$19,519,000137,577
+100.0%
4.92%
TWST BuyTWIST BIOSCIENCE CORP$19,049,000
+65.2%
420,510
+11.5%
4.80%
+7.6%
NVRO BuyNEVRO CORP$17,978,000
+28.4%
150,485
+7.5%
4.53%
-16.4%
MOH BuyMOLINA HEALTHCARE INC$17,798,000
+36.8%
100,000
+7.4%
4.48%
-10.9%
BMY BuyBRISTOL-MYERS SQUIBB CO$16,917,000
+21.4%
287,710
+15.1%
4.26%
-21.0%
INOV BuyINOVALON HLDGS INC$14,119,000
+85.6%
733,053
+60.5%
3.56%
+20.8%
GH BuyGUARDANT HEALTH INC$13,427,000
+382.3%
165,500
+313.8%
3.38%
+213.9%
MCK BuyMCKESSON CORP$13,041,000
+48.3%
85,000
+30.8%
3.28%
-3.4%
CHNG SellCHANGE HEALTHCARE INC$12,855,000
+10.8%
1,147,800
-1.2%
3.24%
-27.9%
AXNX BuyAXONICS MODULATION TECHNOLOG$12,204,000
+140.1%
347,591
+73.8%
3.07%
+56.3%
BMY NewBRISTOL-MYERS SQUIBB COcall$11,760,000200,000
+100.0%
2.96%
NVST NewENVISTA HOLDINGS CORPORATION$10,545,000500,000
+100.0%
2.66%
INSP NewINSPIRE MED SYS INC$10,099,000116,054
+100.0%
2.54%
ZBH  ZIMMER BIOMET HOLDINGS INC$8,355,000
+18.1%
70,0000.0%2.10%
-23.1%
SGRY NewSURGERY PARTNERS INC$7,829,000676,652
+100.0%
1.97%
ADPT  ADAPTIVE BIOTECHNOLOGIES COR$7,257,000
+74.2%
150,0000.0%1.83%
+13.4%
RPRX NewROYALTY PHARMA PLC$4,855,000100,000
+100.0%
1.22%
BKD ExitBROOKDALE SR LIVING INC$0-1,500,000
-100.0%
-1.81%
DXCM ExitDEXCOM INC$0-20,000
-100.0%
-2.08%
HRTX ExitHERON THERAPEUTICS INC$0-500,000
-100.0%
-2.27%
SDGR ExitSCHRODINGER INC$0-150,000
-100.0%
-2.50%
ISRG ExitINTUITIVE SURGICAL INC$0-14,000
-100.0%
-2.68%
HCA ExitHCA HEALTHCARE INC$0-80,000
-100.0%
-2.78%
TEVA ExitTEVA PHARMACEUTICAL INDS LTDsponsored ads$0-1,000,000
-100.0%
-3.47%
ABC ExitAMERISOURCEBERGEN CORP$0-110,000
-100.0%
-3.77%
HUM ExitHUMANA INC$0-40,000
-100.0%
-4.86%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HORIZON THERAPEUTICS PUB LTD12Q3 20229.0%
GUARDANT HEALTH INC12Q3 20226.1%
CHARLES RIV LABS INTL INC11Q1 20237.8%
SURGERY PARTNERS INC11Q2 20236.4%
ICON PLC10Q3 202311.7%
BOSTON SCIENTIFIC CORP10Q3 20238.9%
NEVRO CORP10Q1 20226.7%
DEXCOM INC10Q3 20237.7%
ABBVIE INC9Q3 20238.1%
ACADIA HEALTHCARE COMPANY IN9Q3 20237.9%

View Iron Triangle Partners LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Iron Triangle Partners LP's complete filings history.

Compare quarters

Export Iron Triangle Partners LP's holdings